You’re already in several markets. Some work. Some don’t. The tool for this is the market verdict: a four-box call built on two inputs, unit economics health and market appeal.
It tells you whether to SCALE, FIX, MILK, or EXIT each market. No politics. No guessing. The verdict comes from the numbers.
Rhetica is a B2B international-expansion and DTC growth consultancy that builds and operates new-market revenue.
How do you reach a Scale-Fix-Milk-Exit verdict on a market?
> To reach a verdict, score the market on payback and growth ceiling using its own P&L, then map it to one of Rhetica’s four calls: Scale (pays back and can grow), Fix (broken but fixable), Milk (capped but profitable), Exit (cannot pay back). The verdict turns a vague “is this market working” debate into a single defensible decision.
This piece shows how to apply that verdict to a live market. Want the wider view first? Read the full Scale-Fix-Milk-Exit decision framework and the market-selection and exit framework.
Most Brands Are Running Markets on Autopilot
I keep seeing this again and again. A brand hits $15M in domestic revenue, expands into five or six markets, and then just runs them.
Same budget. Same reporting cadence. No one asking whether Germany earns its cost, or whether Japan should get 3x the spend it’s getting.
The logic most founders use is volume. More markets equals more customers equals more revenue. That is not wrong, but it is incomplete.
It tells you nothing about whether each market earns its cost. It doesn’t show if a market is taking team time from better ones, or quietly killing margin while the P&L looks fine at the top line.
The real mistake is treating all markets the same. A market at $600K with a 42% margin needs a different call than a market at $600K with a 4% margin. The number at the top is the same. The picture below it is not.
What you need is a market verdict for each market. A structured call, not an opinion. Here’s the framework.
The SCALE/FIX/MILK/EXIT Matrix
The matrix runs on two axes.
The Y axis is unit economics health. This is your contribution margin per market, pulled from the per-market P&L behind the verdict, after local CAC, duties, returns, fulfillment, and payment costs come out. Healthy means the market earns a profit at the order level. Unhealthy means you’re paying to be in it.
The X axis is market attractiveness. This is a composite score: total addressable market for your category, competitive density, your CVR vs. domestic baseline, and the cost to build real share. High score means the market rewards investment. Low score means it caps out.
Cross them, and you get four verdicts.
| High Market Attractiveness | Low Market Attractiveness | |
|---|---|---|
| Healthy Unit Economics | SCALE: double down | MILK: take profit, don’t reinvest |
| Unhealthy Unit Economics | FIX: diagnose and fix the leak | EXIT: leave with dignity |
That’s it. Each quadrant has one and only one right answer.
Scoring the X Axis
Market attractiveness is a composite of four inputs. Each is scored 1-5, then weighted.
| Input | Weight | Why this weight |
|---|---|---|
| TAM for your category | 30% | TAM sets the ceiling. A market with $50M for skincare can take more spend. One with $8M cannot. |
| Competitive density | 25% | Density sets the cost of real share. Two rivals with 60%+ organic share each add 30-40% to your CAC. |
| CVR vs. domestic baseline | 25% | CVR gap is the clearest sign that the product fits. A market at 1.5x+ domestic CVR converts without force. |
| Cost to build real share | 20% | This covers media CPMs, local creative, and legal setup. High cost-to-share markets eat margin before the category pays back. |
Score each input 1-5, then apply weights. Above 3.5 weighted average is high-appeal. Below 2.5 is low-appeal. Between 2.5 and 3.5 run a 90-day test.
Scored example: Japan: TAM=4 (large, growing), density=3 (no single 60%+ holder), CVR=5 (1.8x domestic), cost-to-share=3 (setup cost, no ongoing drag). Score: (4×0.30)+(3×0.25)+(5×0.25)+(3×0.20) = 1.20+0.75+1.25+0.60 = 3.80. High appeal. SCALE.
SCALE: Double Down Without Hesitation
Unit economics are healthy and the market has room to grow. This is the only quadrant where raising spend is right. Not holding spend. Raising it.
Most brands in this position under-invest because the domestic market feels safer. That’s a mistake. A SCALE market is telling you the model works here.
The product converts. The margin holds. The category has space.
Holding back is not caution. It’s leaving money for a competitor to take.
The SCALE decision should trigger a resource shift: more budget, local hires if needed, local creative, and a payback by market target within 3-6 months.
FIX: The Market Is Worth Saving, But Something Is Broken
Attractive market, bad unit economics. This quadrant is the most dangerous because it feels like it’s working. Revenue is coming in. Customers are buying.
But the margin is gone by the time you pay for local CAC, duties, and returns.
FIX needs a diagnosis before any spend decision. The 3-layer funnel analysis that informs the verdict is how you find the leak. Four common leaks: CAC running 4-6x above your domestic baseline because creative isn’t localized; AOV down 30-40% after price changes and duties; returns at 2x domestic rate from sizing or slow delivery; payment friction cutting checkout by 15-25 points.
Fix the leak first. Do not increase investment into a FIX market. You are not buying growth. You are funding a broken funnel.
MILK: Take the Cash, Stop Feeding It
Healthy unit economics, limited upside. The market earns a profit but the ceiling is clear. Demographic limits, category age, low search volume, or heavy competition mean this market will not pay back extra spend.
MILK means cutting spend to a low base level, filling demand organically, and stopping the push to grow this market. The cash it throws off should go into SCALE markets.
Brands almost never do this voluntarily. MILK feels like giving up. It is not. It is capital discipline.
A market generating $400K at 38% contribution margin on a $30K annual budget is a healthy asset. That same market on a $180K budget is a waste.
EXIT: Leave Before It Gets Expensive
Bad unit economics, low market attractiveness. More time or money will not change the math here.
EXIT does not mean failure. It means the diagnosis was right and the verdict is clear. A clean exit means running down inventory, pausing paid acquisition, and sending organic demand to a waitlist page. Write down what you learned so the next market check doesn’t repeat the same mistake.
Brands that handle EXIT well get the cash back within a quarter and put it into SCALE markets. Brands that resist EXIT spend 18 months and another $200K trying to prove the market can work.
A $20M Skincare Brand, Six Markets, Six Verdicts
A skincare brand at $20M in revenue, 3 years into international, running in Japan, Germany, Australia, Brazil, the UK, and Canada. Here is the verdict for four of them.
Japan: SCALE. Contribution margin at 34% after local fulfillment. CVR at 1.8x the domestic baseline. Strong search demand for the hero SKU.
Category is not saturated. The brand has a clear edge against domestic alternatives.
Japan’s gifting windows (Obon in August, Oseibo in December) drive 35-45% of annual skincare gift volume. A convenience-store-pay option (FamiPay, 7-Eleven Pay) cuts checkout drop for the 22% of buyers who carry no credit card. Verdict: raise spend, localize creative for both windows, add store-pay before August.
Germany: FIX. Revenue looks fine on the surface, around $380K. Contribution margin at 6%. The leak is CAC: German Facebook CPMs run 3.2x the US rate and the creative is translated English copy, not German-native messaging.
Returns are at 28% (domestic is 11%) because size guides weren’t converted. Both are fixable. Verdict: pause spend, rebuild creative with German-native copy, add a size tool, reassess in 90 days.
Australia: MILK. Strong margin at 41%. Low upside. The category is mature and the market is small.
The top two Australian rivals hold 60-70% of organic search share in the hero SKU class, with 30% split across eight or more smaller brands. The paid CPM floor runs 1.9x the US rate, so any push on paid spend drives the 41% margin toward FIX fast. The brand earns here without trying. Verdict: cut spend to a hold budget, take the margin, stop treating Australia as a growth market.
Brazil: EXIT. Contribution margin at negative 3% after duties (Brazil’s import duty on cosmetics runs 35-60%). CVR at 0.4x domestic. Logistics give a 4-week average delivery window with 18% loss or damage.
Market attractiveness is also low. Brazilian skincare is owned by local brands with distribution edges no foreign brand can match cheaply. Verdict: wind down over 60 days, move budget to Japan.
Why Most Agencies Cannot Give You This Answer
EXIT, and to a lesser extent MILK, needs something most international agencies cannot give: a fee structure that does not punish the verdict.
Bundled execution agencies run on market activity. An EXIT in Brazil removes a paid media line from the retainer. A MILK in Australia cuts their media fee by 60-70%. The kill criteria for a market end the engagement for the team managing it.
Their analysis is not dishonest. The structural problem is that the financial incentive runs against the right call. An agency running your Brazil paid media does not decide in a vacuum whether Brazil is worth keeping. They decide with a retainer at stake.
The same problem applies to cross-border SaaS platforms. They earn on GMV. A verdict that cuts GMV cuts their revenue.
Rhetica charges a flat fee for market verdicts. The fee is the same whether the verdict is SCALE, FIX, MILK, or EXIT. No retainer follows unless the client asks for one. That is the exact reason EXIT is a real call: no line item goes away when we tell a client to stop.
One redacted case: a DTC brand in three markets came in expecting a SCALE recommendation for their second-largest market by revenue. The diagnosis showed contribution margin at 8% after local CAC and duties, with a market attractiveness score of 2.2 on the weighted rubric. Verdict: EXIT.
The brand resisted for six weeks, then wound down. They recovered $340K in working capital and redeployed it into the SCALE market. The engagement ended at the diagnostic. That is what the fee structure makes possible.
Frequently Asked Questions
How do I calculate unit economics health for the Y axis?
Start with revenue per market. Subtract: local CAC (not blended), duties and import fees, local fulfillment costs, returns multiplied by product cost, and local payment processing.
What’s left is your contribution margin per geography. Above 20%, you’re healthy. Below 10%, you’re in FIX or EXIT territory.
What if a market is right on the border between quadrants?
Run a 90-day controlled test. Increase spend by 30% and hold everything else constant. If contribution margin holds or improves, the unit economics are stronger than they appear.
If margin compresses, you have a FIX or EXIT situation. The test costs a defined budget. The alternative is 12 months of ambiguity.
Can we run this framework quarterly?
Yes, and you should. Scores shift with new rivals, category saturation, and macro changes. Payback by market should be reviewed each quarter. Full verdicts should be reviewed once a year, or when a market shows a 15-point swing in contribution margin over two months in a row.
What does a good EXIT actually look like operationally?
Stop paid spend first. Run down existing inventory through organic and CRM channels over 60-90 days. Set up a redirect or waitlist page for any leftover search traffic.
Log the unit economics in your expansion thesis so the next market check starts with this data. A clean exit takes 90 days and gets back most working capital within a quarter.
Is the matrix different for B2B brands?
The axes are the same. For B2B, unit economics uses sales cycle cost, contract value, and renewal rate by market instead of CAC and AOV. Attractiveness uses total addressable accounts and regulatory friction. The four verdicts apply the same way.
Get a 1-Page Market Verdict for Your Markets
If you’ve been running markets on autopilot, the starting point is a written verdict for each one. The Rhetica Market Verdict Scoping delivers a 1-page written report per market covering: weighted attractiveness score (TAM, competitive density, CVR vs. domestic baseline, cost-to-build-share), contribution margin per geography calculated from your actual numbers, and a written SCALE/FIX/MILK/EXIT verdict with the specific action it requires. Covers up to 3 markets. Delivered in writing before the call, so the call is a review, not a pitch.
Request the Market Verdict Scoping
Author: Aliyan Ahmed, Founder of Rhetica. 12 DTC brands personally launched into new markets. $105M+ in international revenue across 60+ countries. Operator, not advisor.